Efficacy and Safety of Chinese Herbal Medicine in Patients with Acute Intracerebral Hemorrhage: Protocol for a Randomized Placebo-Controlled Double-Blinded Multicenter Trial.
Journal:
Cerebrovascular diseases (Basel, Switzerland)
PMID:
39250890
Abstract
INTRODUCTION: The popular traditional Chinese medicine (TCM) compound FYTF-919 (Zhong Feng Xing Nao prescription) may improve outcome from acute intracerebral hemorrhage (ICH) through effects on brain edema, hematoma absorption, and the immune system. This study is to assess whether FYTF-919 is safe and effective as compared to matching placebo treatment in patients with acute ICH.
Authors
Keywords
Acute Disease
Adult
Aged
Cerebral Hemorrhage
China
Disability Evaluation
Double-Blind Method
Drugs, Chinese Herbal
Female
Functional Status
Humans
Male
Middle Aged
Multicenter Studies as Topic
Prospective Studies
Randomized Controlled Trials as Topic
Recovery of Function
Time Factors
Treatment Outcome